4/5/2022 7:39:21 AM
OpGen Announces Interim Analysis Results From Clinical Trial For Unyvero Urinary Tract Infection Panel
6/7/2021 7:38:53 AM
OpGen Submits Updated 510(k) Summary To FDA For Acuitas AMR Gene Panel For Isolates
1/13/2021 7:35:02 AM
OpGen Q4 Revenue $1.3 Mln Vs $0.8 Mln Last Year